Terhormon: A Renewed Center of Excellence
Over the past year, Terhormon has undergone a profound transformation. Following significant investments in infrastructure, process upgrades, and quality systems, the Italian authorities have reviewed and renewed the company’s EU-GMP authorization.
Today, Terhormon operates as a state-of-the-art, EU-based, facility, equipped with a high-standard Quality Management System (QMS) and modernized production lines. The site is now fully ready to supply EU-made, GMP-grade pancreatin API for the most demanding pharmaceutical applications.
A Strategic Step in Natix’s Growth Vision
Natix, a specialist in natural and bioactive ingredients for food, nutraceutical, and pharmaceutical applications, is part of the Floridienne Group, listed on Euronext Brussels. The acquisition of Terhormon strengthens Natix’s position in the pharma enzyme segment, alongside its established operations in GMP grade papain, bromelain, trypsin, and pancrelipase.
“By joining forces with Terhormon, we are securing a sustainable and competitive European source of pharma-grade pancreatin,” said Stefaan Vandaele, CEO of Natix.
“This is a key milestone in our ambition to build Natix into the European leader in high-quality, GMP-certified enzymatic APIs and performant natural bioactives.”
Commitment to the Future
“This agreement ensures the continuity of Terhormon, preserves its heritage, and opens the door to renewed investment and innovation,” added Umberto Cavallazzi, CEO of Terhormon. “We count on the commitment and expertise of our teams to turn this promise into reality and position Terhormon as a European benchmark for quality and reliability.”
Together, Natix and Terhormon are building a strong, sustainable foundation for the future — combining European pharmaceutical know-how with Natix’s international experience and long-term vision.
About Terhormon
Terhormon is an EU-based API producer specializing in pharma-grade pancreatin. Founded in 1971 and located in northern Italy, the company has a longstanding partnership with Natix. Recently renovated to meet the highest international pharma standards, Terhormon now operates a state-of-the-art GMP facility ready to meet the growing demand for high-quality, EU-made pancreatin APIs.
